$EMBK News: Embark Holdings Inc. Acquires Muscle Warfare, Inc. as a Wholly Owned Subsidiary

Mission Viejo, CA - (http://www.FinancialNewsMedia.com News Alert) - Embark Holdings, Inc. (OTC: EMBK) a leader in providing research, evaluation and acquisition services to businesses throughout the world, announced acquiring 100% of Muscle Warfare, Inc. (http://musclewarfare.com) a company that develops, manufactures, and markets sports nutrition products of the highest quality for athletes around the world in all sports, including both professional and amateur enthusiasts. The acquisition consisted of preferred shares in Embark Holdings, Inc.



Muscle Warfare products are certified banned substance free by the World Anti-Doping Agency (\"WADA\") standards and are tested in one of the most elite testing labs in the world called HFL Sport Science, the world\'s largest and most experienced sports test laboratory. The HFL laboratory is ISO Certified and accredited for forensic testing and meets or exceeds world anti-doping agency standards and requirements. The company\'s processes insure that the product offerings distributed are free of inadvertent contaminants and are not deliberately spiked with contaminant compounds by many raw material manufacturers. Additionally, all Muscle Warfare products are manufactured in facilities that are NSF International \"third party audited\" and certified to meet or exceed, Good Manufacturing Practice (\"GMP\") guidelines. GMP quality assurance also insures all raw materials used in our products \'meet spec\' and are what they claim to be.



Since 2008 Muscle Warfare, Inc. has been led by Mr. Daniel Amato. For the past 13 years he has been recognized as a proven winner within the industry with many successes and proven track record marketing and branding sports nutrition products through multiple brands and marketing strategies.



Muscle Warfare has reached approximately $1.9 million in sales in 2011, however, in 2012 Muscle Warfare performed a calculated pull back of sales distribution to successfully navigate an industry wide FDA notice on the ingredient DMAA, which restricted sales industry wide. \"We expected to hit 3-4 Million in sales in 2012 with strong profits. Instead, we decided to utilize this time to carefully rebrand our products to be banned substance free and create formulations that were even more effective. During...